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ABSTRACT1
For the first time, impedance pneumography (IP) enables a continuous analysis of the tidal breathing2
flow volume (TBFV), overnight. We studied how corticosteroid inhalation treatments, sleep stage, and3
time from sleep onset modify the nocturnal TBFV profiles of children. Seventy children, 1-5 years old4
and with recurrent wheezing, underwent three, full-night TBFVs recordings at home, using IP. The first5
recorded one week before ending a 3-months inhaled corticosteroids treatment, and remaining two,6
2 and 4 weeks after treatment. TBFV profiles were grouped by hour from sleep onset and estimated7
sleep stage. Compared with on-medication, the off-medication profiles showed lower volume at8
exhalation peak flow, earlier interruption of expiration, and less convex middle expiration. The9
differences in the first two features were significant during non-rapid eye movement (NREM), and the10
differences in the third were more prominent during REM after 4 h of sleep. These combinations of11
TBFV features, sleep phase, and sleep time potentially indicate airflow limitation in young children.12
13
14
KEYWORDS: lung function, tidal breathing, wheezing children, impedance pneumography15
16
1. INTRODUCTION1
Tidal breathing flow volume (TBFV) analysis has been proposed as an alternative for detecting lower-2
airway obstruction in young children who are unable to cooperate with forced spirometry (Beydon et3
al., 2007). However, interpretation of TBFV profiles, particularly the expiratory limb, is challenging4
(Bates, 1998). Expiration is shaped not only by passive mechanical characteristics such as5
thoracopulmonary recoil and airway resistance (Otis et al., 1950), but also by the active braking during6
the early part of expiration and the active interruption of the expiration ending (Hutten et al., 2008).7
Airway narrowing directly alters passive characteristics, which triggers subject-dependent active8
adaptation strategies (Baldwin et al., 2006; Maarsingh et al., 2000; Morris and Lane, 1981). Moreover,9
passive and active characteristics are influenced by other factors such as instrumentation (Fleming et10
al., 1982), awareness state (Lodrup-Carlsen and Carlsen, 1993), and other respiratory conditions11
(Leonhardt et al., 2010).12
Impedance pneumography (IP) allows the continuous recording of the tidal flow overnight, providing13
several advantages to TBFV profile analysis. Firstly, IP uses four surface skin electrodes to derive the14
respiratory flow noninvasively, from changes in the thoracic electrical impedance, which is15
proportional to lung aeration. Hence, unlike conventional pneumography (PNT) (Fleming et al., 1982),16
IP does not corrupt the shape of the TBFV profiles. Secondly, sleep is characterised by a decrease in17
respiratory musculature tone, which is accentuated further during the rapid eye movement (REM)18
stage (Horner, 2010). It has been hypothesized that a decrease in muscle tone increases the19
contribution of passive characteristics to the TBFV profile, revealing signs of obstruction (Gracia-20
Tabuenca et al., 2019). Thirdly, diseases such as asthma are influenced by many neural, hormonal, and21
autoimmune circadian factors. Asthma symptoms worsen late at night and early in the morning22
(Bohadana et al., 2002). Assessment of the nocturnal TBFV profiles recorded at home may reveal23
symptoms that go unnoticed by tests conducted in hospitals.24
Previous studies have proven the feasibility of using IP to derive TBFV profiles during night sleep25
(Gracia-Tabuenca et al., 2019; Seppä et al., 2016) and the strong agreement between IP and PNT26
results in children (Seppä et al., 2013b) and infants (Malmberg et al., 2017), even under induced27
bronchoconstriction. The effect of interactions between asthma risk and sleep physiology on the28
shape of TBFV profiles has been studied for infants (Gracia-Tabuenca et al., 2019), but not for older29
children. During the first year of life, development of the thoracic cage (Allen and Gripp, 2002) and30
the nervous system (Rabbette et al., 1994) modifies breathing strategy. For example, dynamic31
maintenance of end-expiratory volume decreases (Colin et al., 1989), thoracoabdominal asynchrony32
(Guilleminault et al., 1982) decreases, and respiratory apnoeas become less common (Flores-Guevara33
et al., 1982). It is unknown if these developmental changes affect the results observed in infants.1
Finally, lower airway obstruction increases with night progression, at least in adults with and without2
asthma (Bellia et al., 1989). However, whether TBFV profiles change with night progression has not3
been studied.4
The present longitudinal study assessed the effect that the interruption of medication had on the TBFV5
profiles obtained from overnight IP recordings taken at home, for a group of wheezing children. It also6
investigated the extent to which the time from sleep onset, as well as REM and non-REM sleep stages,7
influenced these changes. These two main sleep stages were respectively estimated from regions of8
high and low respiration variability.9
10
2. MATERIALS AND METHODS11
2.1 Study subjects and data collection12
Seventy children (age = 2.5 (0.9-5.7) years old (median and range)), who were prescribed 3 months13
of fluticasone propionate treatment --based on Finnish guidelines for obstructive bronchitis-- were14
enrolled in our study at Tampere University Hospital. Each patient had IP and electrocardiography15
(ECG) signals recorded at home for three nights. The first recording (Week -1) was performed 1 week16
before conclusion of the fluticasone treatment, and the second (Week 2) and third (Week 4)17
recordings were performed 2 and 4 weeks after treatment ended. Recordings were obtained using a18
custom-designed device developed at Tampere University of Technology (Seppä et al., 2013b).19
Electrode placement was as previously described (Seppä et al., 2013a). On the first recording day20
(Week -1), a trained nurse placed the electrodes and the device on the patient at the hospital and21
instructed the parents on the procedure. For the following recordings (Week 2 and Week 4), the22
parents placed and activated the device at home. A nurse contacted the families to confirm the23
planned recording nights. In all cases, the device started recording before the patient went to sleep24
and recorded until after the patient woke up the next morning. On each recording day, parents25
photographed the electrode locations and noted the time of sleep onset, wake-up time, periods of26
nocturnal awakening, times of bronchodilator intake, and respiratory symptoms, usually coughing,27
sneezing, and rhinorrhoea. Patients were classified according to the following two classification28
criteria. For the first classification  criteria, a paediatric pulmonologist followed the patients for 629
months after the last recording and classified them as current asthma (CA-Y) if they had been30
prescribed a regular asthma controller, reported difficult nocturnal coughing, exercise-induced31
coughing, or shortness of breath relieved by the bronchodilator; possible current asthma (CA-P) if they32
did not fulfil the preceding criteria but were prescribed intermittent controller medication for treating33
asthma symptoms; and no current asthma (CA-N) otherwise. For the second classification criterion,1
patients were classified as atopic if they responded positively in a skin-prick test against egg, cat, dog,2
birch, or timothy, or nonatopic otherwise. Classification criterion, demographic data, and3
bronchodilator use are summarised in Table 1. The Regional Ethics Committee of Tampere University4
Hospital approved the research protocol (Ethics Committee Code R14027), and the ethical guidelines5
of the Declaration of Helsinki were followed.6
2.2 Data preprocessing7
All the recordings were visually inspected by trained researchers who were blind to patient8
information. The researchers discarded sections corrupted by motion or other distorting events such9
as coughing, moving, or talking. Accepted sections of the recordings were automatically processed to10
derive minute-by-minute TBFV profiles, as previously detailed (Gracia-Tabuenca et al., 2019). In short,11
the ECG signal was used to filter out the cardiac artefact from the raw IP signal (Seppä et al., 2011). A12
Savitzky-Golay filter differentiated the resulting lung volume-oriented IP signal into a flow-oriented13
IP signal (Seppä et al., 2010), the remaining noise of which was further attenuated using a nonlinear14
projection filter (Gracia et al., 2017). Cleaned-up flow and volume IP signals were split into respiratory15
cycles, as recommended by Schmidt et al. (1998), and cycles were transformed into TBFV profiles.16
Resulting TBFV profiles were averaged in the flow-volume domain, as described by Sato and Robbins17
(2001), using a 20-TBFV moving window with a 5-TBFV overlap. Each averaged TBFV profile was18
normalised to unit volume and flow-scaled, making its time integral equal to 1 (Sato and Robbins,19
2001).20
For each profile, the following expiratory indices were measured as recommend by Bates et al., 2000;21
and Beydon et al., 2007: expiratory time (TE), time to peak tidal expiratory flow (TPTEF), their ratio22
(TPTEF/TE), equivalent volume ratio (VPTEF/VE), tidal expiratory flow when 50%, 25%, and 5% of the tidal23
volume remains in the lungs relative to peak tidal expiratory flow (TEF50/PTEF, TEF25/PTEF, and24
TEF05/PTEF, respectively). In addition, the index PFV was calculated as the exponent of a power25
function fitted between PTEF and TEF05, as described previously (Gracia-Tabuenca et al., 2019). Figure26
1 shows the indices measured in four representative profiles.27
2.3 Sleep segmentation28
The overnight recordings were segmented on the basis of two different methods: regions of high and29
low respiratory rate variability and time from sleep onset. Regions of high and low variability were30
automatically defined using a method similar to that proposed by Isler et al. (2016). In short, a31
respiration variability time series was formed using the median absolute deviation (MAD) of the32
interbreath intervals (IBI) within a moving 5-min 50% overlap window. Subsequently, a line was fitted1
to the variability time series and crossing points were marked. Regions of 5 min around the crossing2
points were discarded. The remaining sections with the most samples over the fitted line were defined3
as REM and NREM otherwise. An example of the process is shown in Figure 2. Although this4
implementation could not be validated against polysomnography, the performance of our method5
was putatively similar to that of the Isler et al. method (see the Discussion section). The time from6
sleep onset regions were defined as 3-h bins centred at each hour starting from sleep onset. A7
representative recording is shown in Figure 2. Sleep-onset time was set automatically as the beginning8
of the first segment that had no motion artefacts for more than 5 min. Only one automatic sleep onset9
was detected more than an hour before the time annotated by the parents. It was considered an error10
and the annotated time was used.11
2.4 Statistical analysis12
In each recording, we calculated for each index the median of all-night values within the REM sections13
and the median of all-night values within the NREM sections. Similarly, in each recording, we14
calculated for each index and for each hourly bin the median of the REM values and the median of the15
NREM values within each 3-h bin. If the number of indices within a bin was fewer than 20, that bin16
was rejected. The same two procedures were followed for IBI, heart rate, and MAD(IBI) signals. The17
following tests were performed on both: all-night medians (Table 2) and hourly bin medians (Figure18
3). Wilcoxon rank sum was used to assess the differences between the REM and NREM medians within19
each recording, separately for the three recording weeks. The same test was used to assess the20
differences between recording weeks for each subject, separately for REM and NREM. The differences21
between groups within each classification criterion and between bronchodilator use and no use were22
assessed for each index, in each sleep stage, and in each recording day using the Wilcoxon rank sum23
test. The characteristics of the subjects between groups or bronchodilator use were compared using24
the Kruskal-Wallis test for continuous variables or the c2/Fisher’s exact test for categorical variables25
(Table 1). Bonferroni correction was applied in all tests. Moreover, Spearman rank correlation26
coefficients were calculated between all-night median values and patient age for all weeks (Table 3).27
3. RESULTS28
Twenty-two recordings were rejected due to battery or electrode problems, or malfunctioning of the29
prototype recorders. For the accepted recordings, the starting time was at a mean of 9:20 pm (±1:05)30
and lasted 9.95 (±1.11) h (mean value (standard deviation). Of the accepted data, 28.33% (±4.47%)31
was discarded for being corrupted or occurring between sleep stages, and 25.17% (±5.93%) was32
classified as REM, slightly higher than reported by Traeger et al. (2005). Table 2 shows that neither1
faulty recordings nor sleep efficiency depended on the recording week, and summarises all-night2
medians for each index and recording week. Hourly bin medians for six selected indices and three3
recording weeks are summarised in Figure 3.4
MAD (IBI), heart rate, and respiratory rate showed similar results in on-medication and off-medication5
recording weeks. Evidently, IBI variability was higher during REM than during NREM the whole night.6
Only respiratory variability, respiratory rate, and TE presented a weak but significant correlation (p <7
0.05) with the patients’ age for some combinations of sleep stage and recording day. However, heart8
rate had a significant correlation with age (p < 0.001) for all stages and ages (Table 3). The correlation9
of age with heart rate, and less significantly with respiratory rate, agrees with published results10
(Scholle et al., 2011).11
For the on-medication recordings (Week -1), absolute times TE and TPTEF were both significantly shorter12
during REM for the whole night. However, their overnight median trends were different. The TE13
median slightly increased overnight for both sleep stages, whereas the TPTEF median was constant for14
NREM and decreased for REM in the first part of the night. As expected, the overnight median trend15
for TPTEF/TE was the combination of the trend of TPTEF and the inverted trend of TE. For VPTEF/VE, the16
trend of TE was no longer present, but both NREM and REM presented a trend similar to that of TPTEF.17
However, unlike with TPTEF, for VPTEF/VE, the NREM and REM median trends overlapped with each other18
and, therefore, showed no significant differences overnight. On the end side of the TBFV profiles,19
TEF05/PTEF was significantly lower for REM than for NREM during the whole night. In the middle part20
of the profiles, PVF showed a constant median during the whole night for NREM and REM. On the other21
hand, TEF50/PTEF and TEF25/PTEF showed a decreasing trend, similar to that of VPTEF/VE, and a sleep-22
stage differentiation similar to that of TEF05/PTEF. The time progression of TEF50/PTEF and23
TEF25/PTEF seemed to be a combination of VPTEF/VE and TEF05/PTEF (not shown in Figure 3).24
A comparison of the indices for on-medication (Week -1) with those for off-medication (Week 2 and25
Week 4) showed there were no significant differences in IBI variability, heart rate, and respiratory26
rate. Overnight median trends for TE, TPTEF, TPTEF/TE, and VPTEF/VE presented night progressions for off-27
medication similar to those for on-medication. However, in the Week 4 recordings, all-night medians28
for TPTEF, TPTEF/TE, and VPTEF/VE were significantly lower during NREM. The most significant difference29
was observed for VPTEF/VE (p = 0.0019), which also showed a significant decrease for all hourly bin30
medians. Likewise, TEF05/PTEF increased in the Week 4 recordings for both sleep stages, but the31
increase was statistically significant for all hourly bin medians only for NREM. Unlike in Week -1, PVF32
significantly increased in Week 4 for both sleep stages, but only in the second half of the night.1
Moreover, the increase in PVF was higher for REM than for NREM.2
Current asthma and skin-prick test classifications showed no significant differences for any index in3
any sleep stage on any recording day. However, the use of a bronchodilator showed significant4
differences (p < 0.01) in Week 4 for both sleep stages for all the indices in the middle part except5
TEF25/PTEF in NREM. Counterintuitively, the values of subjects who used a bronchodilator suggest6
that they presented greater obstruction than subject who did not use: during REM, PVF was 0.89 (0.837
1.04) (median (interquartile range)) for bronchodilator use vs. no use 0.71 (0.67 0.77); TEF25/PTEF8
was 0.44 (0.39 0.46) vs. 0.53 (0.50 0.57); and TEF50/PTEF was 0.74 (0.68 0.77) vs. 0.82 (0.79 0.87).9
Similarly, during NREM, PVF was 0.82 (0.73 0.92) vs 0.69 (0.64 0.74) and TEF50/PTEF was 0.77 (0.7510
0.81) vs. 0.85 (0.80 0.89).11
12
4. DISCUSSION13
This study demonstrated that dividing the night into regions of higher and lower IBI variability, as an14
estimation of REM and NREM sleep, presented differences in the TBFV indices for both on-medication15
and off-medication recordings in children. Moreover, when assessed at different times from sleep16
onset, certain indices presented a decreasing averaged trend during REM. In addition, the interruption17
of treatment had a different effect on the early and late parts of the expiratory TBFV profile than on18
the middle part. Changes in the early and late expiration were significant during the whole night for19
NREM. Changes in the middle expiration were significant in the second part of the night and larger for20
REM.21
Lower TE and TPTEF values for REM than for NREM have been observed in healthy and wheezing infants22
(Gracia-Tabuenca et al., 2019; Haddad et al., 1979), but not in adolescents (Tabachnik et al., 1981).23
We found that the ratio TPTEF/TE was lower for REM than for NREM but that VPTEF/VE was similar for24
both sleep stages. Such different results for these similar ratios can be explained by comparing the25
late part of expiration on the time and volume domains. For example, the profiles in Figure 1 (A) and26
(B) present similar VPTEF/VE, but TPTEF/TE is lower in (B) because in the late part, expiratory airflow is27
low. Hence, a longer time is needed to produce the same change in volume as in (A), where the flow28
is higher. Thus, our results suggest that for REM sleep, the later part of exhalation was interrupted29
less often, whereas for NREM, exhalation was interrupted more often before reaching resting volume,30
as is also suggested by a higher TEF05/PTEF during REM. Shorter and uninterrupted exhalation during31
REM may be due to the natural decrease in respiratory musculature tone in this sleep stage (Horner32
R.L., 2010). Intercostal atony in REM leads to a more compliant chest that deflates faster  (Mortola et1
al., 1982; Otis et al., 1950). Intercostal atony together with a lower diaphragm tone decreases the2
functional residual capacity (FRC) (Henderson-Smart and Read, 1979). This decrease has been linked3
to uninterrupted or late interruption of expiration (Morris et al., 1998; Schmalisch et al., 2003).4
The overnight decreasing trend in the REM bin medians, which is shared by TPTEF, TPTEF/TE, VPTEF/VE,5
TEF50/PTEF, and TEF25/PTEF, may have been caused by a shortening of post-inspiration inspiratory6
activity (PIIA) during the night. For individuals of all ages, a decrease in TPTEF, and therefore in TPTEF/TE7
and VPTEF/VE, is commonly understood as a shortening of PIIA (Ent et al., 1998). Shorter PIIA would also8
explain the lower TEF50/PTEF and TEF25/PTEF values because decreased expiratory braking leads to9
higher PTEF (Walraven et al., 2003). The shortening of PIIA during the night may be due to multiple10
factors such as a decrease in respiratory musculature tone during the night, as seen in asthmatic adults11
(Steier et al., 2011); an adaptation to a circadian increase in airway resistance (Bellia et al., 1989); or12
other circadian factors (Bohadana et al., 2002). In any case, changes in the sleep stage or night13
progression did not seem to affect the number of concave profiles, as assessed by PVF, or the14
interruption of expiration, as assessed by TEF05/PTEF, at least for Week -1.15
Changes in the off-medication TBFV profiles compared to the on-medication TBFV profiles were16
presumably caused by an increased number of children presenting airflow limitation. Such changes in17
the early, middle, and late parts of expiration agreed with the changes related to airflow limitation18
reported in the following studies. In the early part, the significant decrease in VPTEF/VE, TPTEF/TE, and19
TPTEF was potentially caused by a shortening of PIIA. It has been speculated that individuals with airway20
obstruction have short PIIA braking to accommodate for the slower passive expiration (Carlsen and21
Carlsen, 1994; van der Ent et al., 1996). In the late part, the significant increase in TEF05/PTEF may be22
due to the early interruption of expiration with the purpose of elevating the FRC to increase airway23
calibre (Greenough et al., 1989; Wheatley et al., 1990). In the middle part, the significant increase in24
PVF was most likely due to an increase in concavity, as observed in infants (Benoist et al., 1994) and25
adults (Williams et al., 1998). Bronchodilator use decreases airway obstruction, thus putatively making26
the TBFV profiles less concave. However, our results show that profiles were more concave the days27
where bronchodilator was used. This apparent contradiction can be explained as follows.28
Bronchodilator use occurred mostly before the recording period and its effects are known to wear off29
after a few hours. Therefore, any changes in the profiles because of bronchodilator use were likely30
averaged out over the rest of the recording. Under these assumptions, bronchodilator use indicates31
that on that recording day, parents notice airflow limitation and applied the medication, but for most32
of the recording bronchodilator had no effects. This, together with the lack of correspondence33
between indices and classification criteria, suggests that nocturnal TBFV analysis may better reflect1
occasional  worsening of asthma rather than the presence of the condition.2
Why early and late indices differ during all hourly bins for NREM but not for REM can be explained by3
the decrease in respiratory musculature tone during REM. During NREM, active strategies to4
compensate for obstruction, such as shortening PIIA or interrupting expiration, are potentially5
reflected as changes in early and late expiration. However, during REM, decreased musculature tone6
reduces the strength of active strategies. Why middle expiration differs during the second half of the7
night more strongly for REM can be explained by the increase in lower airway resistance with night8
progression (Bellia et al., 1989) and the decreased musculature tone in REM. During the first half of9
the night, active strategies compensate for lower airway resistance, so middle expiration is less10
affected. The increased resistance overnight, despite active compensation, is reflected as an increase11
in concave middle expiration. During REM, as the decreased musculature tone reduces the strength12
of active strategies, the concavity of middle expiration is accentuated.13
Our study has the following limitations. Firstly, the REM and NREM regions were not based on14
conventional polysomnography but on an indirect classification based on IBI variability. We assumed15
that the accuracy of our method was similar to that of Isler et al. (2016) or greater than this because16
we rejected the 5 min between stages where misclassification is higher. The sensitivity and specificity17
of the method of Isler et al. compared against standard polysomnographic classification, is 83% and18
78% for REM and 78% and 83% for NREM. Additionally, Willemen et al. (2014) have summarised19
several studies on adults which found accuracies greater than 80% when variability in respiratory rate20
was used to separate REM from NREM sleep Secondly, we assumed that IP maintains a high linearity21
with mouth airflow overnight. Physiological changes during NREM and REM could degrade the strong22
agreement between IP and PNT results shown for awake children. Finally, our study group was rather23
heterogeneous. Some patients may not have responded to the medication, some may not have24
presented asthma, and it is unlikely that all nonmedicated asthmatics would have suffered from25
airflow limitation on the recording nights. In addition, our study included a few children younger than26
2 years. Before this age, maturation affects the shape of the TBFV profiles in the late (Colin et al., 1989)27
and early parts (Frey et al., 2001). However, in a previous study, we demonstrated that airflow28
limitation is reflected as an increased concavity of the middle part in infants (Gracia-Tabuenca et al.,29
2019). The current IP technique also has its limitations. Patient movement may cause the detachment30
of the electrodes or contamination of the recordings. In this study, 22 of the 210 recordings had to be31
rejected. Although the correspondence between IP and PNT is independent of posture (Seppä et al.,32
2010), posture could affect respiratory mechanics and hence TBFV shapes (Mayer et al., 2003).33
Alternative electrodes such as textile electrodes and the effects of sleeping posture should be1
researched further.2
3
4
5. CONCLUSION5
We conclude that the analysis of TBFV profiles derived from nocturnal home IP recordings, holds the6
potential to monitor nocturnal symptoms in wheezing children. The IP system is easy to used at home7
on regular bases allowing for a frequent monitoring of patients’ symptoms. Regular monitoring could8
aid  doctors on adapting the appropriate treatment. We observed that the IP of young children with9
recurrent wheezing, who were recorded overnight, was influenced by medication, sleep stage, and10
time from sleep onset. Two indicators may suggest the presence of airflow limitation in children.11
Firstly, an increase in the concavity of the middle expiration during REM in the second half of the night,12
likely caused by the natural decrease in respiratory musculature tone and circadian factors, and,13
secondly, changes in early and late expiration, assessed by VPTEF/VE and TEF05/PTEF, respectively,14
during NREM sleep, likely caused by active obstruction compensatory strategies.15
16
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FIGURE LEGENDS1
2
3
Figure 1. TBFV indices for four representative expiration limbs from the same patient extracted from4
NREM Week -1 (A), REM Week -1 (B), NREM Week 4 (C), and REM Week 4 (D). Upper plots show flow-5
time domain and lower plots show flow-volume domain . Volume is normalized to 1 and flow is scaled6
to have area of 1 in the flow-time domain. Light grey lines represent the expiration signals, vertical7
solid lines between points show distances, and solid line curves are the power-fitted curves, which are8
displaced for clarity and the dotted lines project where the curves should be located. The grey areas9
in the flow-time plots (A) and (B) are regions with the same area. They show that integrating the same10
volume (. ) took a longer time in (B) than in (A) because the flow ( ) was lower ( = ∫ d ).11
1
Figure 2. Two sleep segmentation methods: (upper) segments of high and low respiratory rate2
variability are shown as grey and light-grey boxes, respectively; (lower) solid lines indicate time from3
sleep onset in 3-h segments. The procedure presented in the text is based on the dotted-line signal4
(MAD(IBI)). The dashed line is the linear fit and the black dots are valid crossings. The abscissa shows5
the time from sleep onset in hours.6
7
1
Figure 3. Averaged hourly progression of several indices grouped by recording week and sleep stage.2
Rows correspond to an index and the columns to a recording week. Within each plot, the x-axis is the3
time from sleep onset (in hours) and the y-axis is the index value. Dots and vertical lines are median4
and interquartile ranges of all patients at a given time for NREM (grey) and REM (black). *: significant5
difference (p < 0.01) between sleep stages; a: significant difference (p < 0.05) between Week -1 and6
Week 4; b: significant difference (p < 0.05) between Week 2 and Week 4. Letters on top of vertical7
lines for NREM and letters on bottom for REM. All p values were calculated using the Wilcoxon signed8
sum test after Bonferroni corrections (n = 3).9
Table 1. Characteristics of studied children.1
Current asthma Skin prick
Groups CA-N CA-P CA-Y Nonatopic Atopic
Subjects 16 16 36 40 28
Age [mo] 51.45(18.23 77.07)
54.27
(40.07 80.70)
41.10
(15.73 78.63)
43.87
(17.77 67.50)
51.23
(15.73 80.70)
Male 12 10 22 26 18
Broncho-Week -1 2 0 2 2 2
Broncho-Week 2 1 4 7 9 3
Broncho-Week 4 3 6 7 11 5
2
Subjects were classified according to two classification  criteria: current asthma and skin-prick test.3
The first criteria consist on tree groups: no current asthma (CA-N), probable current asthma (CA-P),4
and current asthma (CA-Y). The second criteria consist on two groups: nonatopic and atopic. Age (in5
months) is given as the median (range). The entries for Broncho-Week -1, Broncho-Week 2, and6
Broncho-Week 4 are the number of subjects who used a bronchodilator in Week -1, Week 2, and Week7
4, respectively. No significant difference was found between groups within each criterion for any8
characteristic as determined by the Kruskal-Wallis test (continuous variables) or the c2/Fisher’s exact9
test (categorical variables).10
Table 2. Median of the TBFV parameters during estimated NREM and REM sections overnight. Values1
are grouped according to the recording week.2
Week -1 Week 2 Week 4
Subjects 62 64 62
TREM/TTotal [%] 0.25 (0.22 0.29) 0.24 (0.21 0.28) 0.24 (0.21 0.29)
MAD(IBI) [s] NREM 0.13 (0.12 0.14) 0.13 (0.11 0.15) 0.13 (0.12 0.14)
REM 0.28 (0.25 0.34) * 0.30 (0.26 0.33) * 0.29 (0.25 0.34) *
Heart rate [bpm] NREM 83.30 (77.37 89.86) 83.53 (75.47 92.11) 84.94 (79.66 92.95)
REM 89.90 (82.54 95.80) * 89.07 (81.85 97.04) * 89.41 (84.91 97.91) *
Mean(IBI) [bpm] NREM 19.33 (18.32 22.35) 19.57 (17.89 21.85) 20.47 (18.21 23.04)
REM 20.44 (18.17 22.01) 19.92 (18.40 22.69) 20.93 (18.93 23.62)
TE [s] NREM 1.85 (1.65 2.00) 1.87 (1.71 2.04) 1.82 (1.59 2.00)
REM 1.71 (1.59 1.92) * 1.75 (1.59 1.96) * 1.64 (1.50 1.94) *
TPTEF [s] NREM 0.32 (0.27 0.37) 0.32 (0.27 0.37) 0.29 (0.24 0.34) a
REM 0.27 (0.24 0.32) * 0.27 (0.24 0.29) * 0.26 (0.22 0.29) *
TPTEF/TE NREM 0.17 (0.15 0.20) 0.17 (0.14 0.20) 0.16 (0.14 0.19) a
REM 0.16 (0.14 0.19) * 0.15 (0.13 0.18) * 0.15 (0.13 0.18) *
VPTEF/VE NREM 0.25 (0.22 0.29) 0.24 (0.21 0.28) 0.23 (0.20 0.27) a
REM 0.26 (0.23 0.28) 0.24 (0.21 0.26) 0.23 (0.21 0.27) a
TEF50/PTEF NREM 0.87 (0.84 0.89) 0.85 (0.80 0.88) 0.84 (0.79 0.88) a, Br
REM 0.85 (0.81 0.88) * 0.81 (0.79 0.86) * 0.80 (0.76 0.87) *, a, b, Br
TEF25/PTEF NREM 0.57 (0.53 0.61) 0.57 (0.51 0.60) 0.53 (0.48 0.60)
REM 0.54 (0.52 0.57) * 0.52 (0.48 0.56) * 0.50 (0.45 0.56) *, a, b, Br
PVF NREM 0.68 (0.64 0.73) 0.69 (0.65 0.75) 0.71 (0.66 0.80)  a, Br
REM 0.69 (0.65 0.75) 0.72 (0.67 0.78) 0.75 (0.68 0.85) *, a, b, Br
TEF05/PTEF NREM 0.13 (0.09 0.16) 0.14 (0.10 0.18) 0.14 (0.10 0.21) a
REM 0.11 (0.09 0.14) * 0.11 (0.08 0.13) * 0.12 (0.08 0.16) *, a
Values are given as median (0.25 0.75 (quartiles)). Columns are recording weeks: Week -1 is one week3
before end of treatment, Week 2 is two weeks after end of treatment, and Week 4 is 4 weeks after4
end of treatment. Indices are defined in the text. *: significant difference (p < 0.01) between sleep5
stages within each week. a: significant difference (p < 0.05) between Week -1 and Week 4. b:6
significant difference (p < 0.05) between Week 2 and Week 4. Significant differences were calculated7
using the Wilcoxon signed sum test. Br: significant difference (p < 0.01) between subjects who used a8
bronchodilator that recording day and subjects who did not, calculated using the Wilcoxon rank sum9
test. Bonferroni correction (n = 3) was applied to all p values.10
11
Table 3. Spearman correlation coefficients between selected indices and patient age during NREM and1
REM recorded in the week under treatment (Week -1).2
Week -1 Week 2 Week 4
MAD(IBI) [s] NREM 0.29 (0.02) * 0.35 (0.01) * 0.13 (0.33)
REM -0.01 (0.97) 0.10 (0.45) -0.01 (0.96)
Heart rate [bpm] NREM -0.42 (0.00) ‡ -0,40 (0.00) ‡ -0.49 (0.00) ‡
REM -0.42 (0.00) ‡ -0.44 (0.00) ‡ -0.50 (0.00) ‡
Respiration rate [bpm] NREM 0.17 (0.17) 0.13 (0.03) * 0.20 (0.13)
REM 0.26 (0.04) * 0.23 (0.04) * 0.33 (0.01) *
TE [s] NREM 0.17 (0.19) 0.13 (0.30) 0.19 (0.14)
REM 0.21 (0.09) 0.23 (0.07) 0.34 (0.01) *
Correlation tested using Spearman’s rank correlation rho (r). *: p < 0.0001, ‡: p < 0.0001. The indices3
not included in the table had a nonsignificant correlation with p > 0.05.4
